跳至内容
· 皮肤填充剂
SKU 11163 · GTIN 010764017323539

Teosyal RHA 3

有货
容量
2 x 1,2 mL
制造商
Teoxane
产地
瑞士
批发价及价格历史仅对已验证账户开放
allpara 仅向持证从业者供货。请登录或申请 B2B 账户,查看实时价格、批量阶梯价及价格历史。

TEOSYAL RHA 3 is a transparent, sterile, non-pyrogenic and viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, designed to correct deep facial wrinkles and deep skin creases. It is also indicated to add volume in the midface and to remodel the lower face. The product contains 23 mg/mL of hyaluronic acid, cross-linked with BDDE at a mean molecular weight above 1 million Dalton, and 0.3% by mass of lidocaine hydrochloride. Each box contains two 1 mL pre-filled syringes, every one with two sterile 27G 1/2 inch needles and two traceability labels.

主要优势: Teosyal RHA 3

  • Corrects deep facial wrinkles and deep skin creases
  • Adds volume in the midface and remodels the lower face
  • Also indicated for the perioral region, including the lips
  • Hyaluronic acid at 23 mg/mL with a degree of cross-linking below 5%
  • Mean molecular weight above 1 million Dalton, of non-animal origin, residual BDDE below 1 ppm
  • Contains lidocaine hydrochloride 0.3% by mass to reduce the sensation of pain
  • Two pre-filled 1 mL syringes per box, each with two sterile 27G 1/2 inch needles
  • Estimated duration of 12 to 18 months
关键信息
品牌 TEOSYAL
制造商 Teoxane SA
原产国 Switzerland
认证 CE marked 2797 for the gel. The needles supplied are CE marked 0123 for TSK or 0197 for Terumo
成分 Hyaluronic acid of non-animal origin 23 mg/mL, mean molecular weight above 1 million Dalton, cross-linked with BDDE (degree of cross-linking below 5%, residual BDDE below 1 ppm); lidocaine hydrochloride 0.3% by mass; phosphate buffer pH 7.3 q.s. ad 1 mL
容量 / 规格 1 ml
包装 2 pre-filled syringes x 1 mL, each supplied with 2 sterile 27G 1/2 inch needles and 2 traceability labels; gel volume marked on the box and on each syringe
使用类型 Professional use only: injectable dermal filler with anaesthetic, for deep wrinkles, midface, lower face and lips; also indicated for reconstructive use
注射深度 Injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, onto the supraperiosteum, or into the subdermis or the submucosa of the red lips. Must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described
方案 / 疗程 Estimated lifetime of 12 to 18 months, depending on skin type, wrinkle severity, injection area, injected volume, and patient physiology and lifestyle

适应症与专业用途

主要适应症

  • Correction of any deep facial wrinkles and deep skin creases
  • Adding volume in the midface
  • Remodelling of the lower face
  • Therapeutic indications: reconstructive surgery, filling of depressions due to scars, and reconstruction of volumes lost by lipoatrophy in patients undergoing HIV treatment

专业用途

TEOSYAL RHA 3 is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law, and is not for retail sale or self-administration. It is injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, onto the supraperiosteum, or into the subdermis or the submucosa of the red lips. Where a cannula is used, an entry point is made in the skin with a sharp needle of appropriate size. It must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described. Depending on the correction required, one or more treatment sessions or a touch-up may be needed.

治疗部位

  • Midface: nasolabial folds, cheeks, nasojugal groove
  • Lower face: chin, jawline
  • Perioral region: lips including the philtrum, marionette lines, oral commissures

适用患者

For adults assessed as suitable by the treating practitioner, typically those with deep creases or midface volume loss rather than fine surface lines. It must not be used in patients with cutaneous disorders, inflammation or infection at or near the treatment site, since injection procedures can lead to reactivation of latent or subclinical herpes viral infection. It must also not be used in patients with a known hypersensitivity to hyaluronic acid with a history of severe allergy or anaphylactic shock, in patients with autoimmune diseases, or in pregnant or breastfeeding women. Because of the lidocaine content it must not be used in patients with known hypersensitivity to lidocaine or to amide local anaesthetics, in patients with cardiac diseases or undergoing treatment for heart disease (beta blockers), in patients with hepatocellular insufficiency or undergoing treatment for a liver disease, or in patients with epilepsy or porphyria. It must not be used in combination with other aesthetic procedures such as peeling, laser treatment or ultrasound-based treatment.

作用原理: Teosyal RHA 3 ​

TEOSYAL RHA 3 works through hyaluronic acid at 23 mg/mL with a degree of cross-linking below 5%, delivered through a wider 27G needle than RHA 1 and RHA 2. Hyaluronic acid binds water and restores volume where tissue has been lost, which is what allows this grade to fill a deep crease and rebuild midface volume.

为什么选择在 Allpara 订购

Allpara 提供正品、经过验证的 TEOSYAL 产品,来自经过严格审核的供应商,具备完整的批次可追溯性和专家支持。我们为诊所和医美专业人士提供CE认证产品、从欧盟仓库快速配送至欧盟各地,以及具有竞争力的专业价格。我们关注的是您患者的安全、满意度和效果,并提供专属售后支持,让您安心无忧。

常见问题

How does Teosyal RHA 3 differ from Teosyal RHA 2 and Teosyal RHA 4?

All three carry 23 mg/mL hyaluronic acid with cross-linking below 5%. Teosyal RHA 2 is for facial wrinkles and creases across four regions, in a 1 ml syringe with 30G needles. Teosyal RHA 3 is for deep wrinkles and midface volume, also in a 1 ml syringe but with 27G needles. Teosyal RHA 4 is for facial contour remodelling in thick skin areas, in a 1.2 ml syringe with 27G needles, and lasts 15 to 18 months rather than 12 to 18.

How long does Teosyal RHA 3 last?

The estimated in vivo lifetime is 12 to 18 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.

更多产品: Teoxane

查看制造商

诊所替代选择

全部产品

Teosyal RHA 3

有货
CE认证 CE认证 Teosyal RHA 3
仅限已验证账户查看价格
请登录或申请 B2B 账户以查看您的价格。
申请 B2B 账户

TEOSYAL RHA 3 is a transparent, sterile, non-pyrogenic and viscoelastic hyaluronic acid filler of non-animal origin from Teoxane SA in Geneva, designed to correct deep facial wrinkles and deep skin creases. It is also indicated to add volume in the midface and to remodel the lower face. The product contains 23 mg/mL of hyaluronic acid, cross-linked with BDDE at a mean molecular weight above 1 million Dalton, and 0.3% by mass of lidocaine hydrochloride. Each box contains two 1 mL pre-filled syringes, every one with two sterile 27G 1/2 inch needles and two traceability labels.

主要优势: Teosyal RHA 3

  • Corrects deep facial wrinkles and deep skin creases
  • Adds volume in the midface and remodels the lower face
  • Also indicated for the perioral region, including the lips
  • Hyaluronic acid at 23 mg/mL with a degree of cross-linking below 5%
  • Mean molecular weight above 1 million Dalton, of non-animal origin, residual BDDE below 1 ppm
  • Contains lidocaine hydrochloride 0.3% by mass to reduce the sensation of pain
  • Two pre-filled 1 mL syringes per box, each with two sterile 27G 1/2 inch needles
  • Estimated duration of 12 to 18 months
关键信息
品牌 TEOSYAL
制造商 Teoxane SA
原产国 Switzerland
认证 CE marked 2797 for the gel. The needles supplied are CE marked 0123 for TSK or 0197 for Terumo
成分 Hyaluronic acid of non-animal origin 23 mg/mL, mean molecular weight above 1 million Dalton, cross-linked with BDDE (degree of cross-linking below 5%, residual BDDE below 1 ppm); lidocaine hydrochloride 0.3% by mass; phosphate buffer pH 7.3 q.s. ad 1 mL
容量 / 规格 1 ml
包装 2 pre-filled syringes x 1 mL, each supplied with 2 sterile 27G 1/2 inch needles and 2 traceability labels; gel volume marked on the box and on each syringe
使用类型 Professional use only: injectable dermal filler with anaesthetic, for deep wrinkles, midface, lower face and lips; also indicated for reconstructive use
注射深度 Injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, onto the supraperiosteum, or into the subdermis or the submucosa of the red lips. Must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described
方案 / 疗程 Estimated lifetime of 12 to 18 months, depending on skin type, wrinkle severity, injection area, injected volume, and patient physiology and lifestyle

适应症与专业用途

主要适应症

  • Correction of any deep facial wrinkles and deep skin creases
  • Adding volume in the midface
  • Remodelling of the lower face
  • Therapeutic indications: reconstructive surgery, filling of depressions due to scars, and reconstruction of volumes lost by lipoatrophy in patients undergoing HIV treatment

专业用途

TEOSYAL RHA 3 is only to be administered by appropriately trained healthcare professionals who are qualified or accredited in accordance with national law, and is not for retail sale or self-administration. It is injected slowly at variable depths depending on the area treated: into the dermis, subcutaneously, onto the supraperiosteum, or into the subdermis or the submucosa of the red lips. Where a cannula is used, an entry point is made in the skin with a sharp needle of appropriate size. It must not be injected into the epidermis, into or close to a blood vessel, close to a nerve, or at depths other than those described. Depending on the correction required, one or more treatment sessions or a touch-up may be needed.

治疗部位

  • Midface: nasolabial folds, cheeks, nasojugal groove
  • Lower face: chin, jawline
  • Perioral region: lips including the philtrum, marionette lines, oral commissures

适用患者

For adults assessed as suitable by the treating practitioner, typically those with deep creases or midface volume loss rather than fine surface lines. It must not be used in patients with cutaneous disorders, inflammation or infection at or near the treatment site, since injection procedures can lead to reactivation of latent or subclinical herpes viral infection. It must also not be used in patients with a known hypersensitivity to hyaluronic acid with a history of severe allergy or anaphylactic shock, in patients with autoimmune diseases, or in pregnant or breastfeeding women. Because of the lidocaine content it must not be used in patients with known hypersensitivity to lidocaine or to amide local anaesthetics, in patients with cardiac diseases or undergoing treatment for heart disease (beta blockers), in patients with hepatocellular insufficiency or undergoing treatment for a liver disease, or in patients with epilepsy or porphyria. It must not be used in combination with other aesthetic procedures such as peeling, laser treatment or ultrasound-based treatment.

作用原理: Teosyal RHA 3 ​

TEOSYAL RHA 3 works through hyaluronic acid at 23 mg/mL with a degree of cross-linking below 5%, delivered through a wider 27G needle than RHA 1 and RHA 2. Hyaluronic acid binds water and restores volume where tissue has been lost, which is what allows this grade to fill a deep crease and rebuild midface volume.

为什么选择在 Allpara 订购

Allpara 提供正品、经过验证的 TEOSYAL 产品,具备完整的批次可追溯性、CE认证库存、欧盟范围内快速配送以及专业的售后支持。

常见问题

How does Teosyal RHA 3 differ from Teosyal RHA 2 and Teosyal RHA 4?

All three carry 23 mg/mL hyaluronic acid with cross-linking below 5%. Teosyal RHA 2 is for facial wrinkles and creases across four regions, in a 1 ml syringe with 30G needles. Teosyal RHA 3 is for deep wrinkles and midface volume, also in a 1 ml syringe but with 27G needles. Teosyal RHA 4 is for facial contour remodelling in thick skin areas, in a 1.2 ml syringe with 27G needles, and lasts 15 to 18 months rather than 12 to 18.

How long does Teosyal RHA 3 last?

The estimated in vivo lifetime is 12 to 18 months. Duration depends on skin type, the severity of the wrinkle treated, the injection area, the volume injected, and the patient's physiology and lifestyle.

更多产品: Teoxane

查看制造商 →
* 专业用途产品。包装可能因批次或市场而异。完整的使用说明和禁忌症请参阅随附的使用说明书。